Blue Jet Healthcare Limited (NSE:BLUEJET)

Market Cap	146.33B
Revenue (ttm)	10.30B
Net Income (ttm)	3.05B
Shares Out	173.47M
EPS (ttm)	17.59
PE Ratio	47.96
Forward PE	40.21
Dividend	1.20 (0.14%)
Ex-Dividend Date	n/a

Volume	113,312
Average Volume	306,897
Open	848.05
Previous Close	843.55
Day's Range	829.95 - 850.00
52-Week Range	400.00 - 986.00
Beta	n/a
RSI	47.74
Earnings Date	Jul 29, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 447
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In 2024, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.